HEALTH● LOWJul 22 · Jul 22, 2026, 5:56 PM
GSK enters lung cancer market with FDA nod for Jideytro
Seeking Alpha Tech
GSK has received FDA approval for Jideytro, allowing the company to enter the lung cancer market. This approval introduces a new treatment option for lung cancer.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH58m agoEbola: Nigeria may declare outbreak over in December – MinisterPremium TimesHEALTHBREAKING59m agoNurse accused of spreading Ebola murdered by mobThe TelegraphHEALTH1h agoEbola: Plateau reopens isolation centres, steps up surveillancePremium TimesHEALTH1h agoEbola: Resident doctors demand urgent hospital preparedness, protection of frontline workersPremium Times